Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last R$20.26 BRL
Change Today +0.11 / 0.55%
Volume 1.7M
HYPE3 On Other Exchanges
Sao Paulo
As of 4:11 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

hypermarcas sa (HYPE3) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/23/15 - R$23.48
52 Week Low
10/27/14 - R$15.31
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for HYPERMARCAS SA (HYPE3)

Related News

No related news articles were found.

hypermarcas sa (HYPE3) Related Businessweek News

No Related Businessweek News Found

hypermarcas sa (HYPE3) Details

Hypermarcas S.A., a consumer goods company, engages in the development, production, and sale of drug, health, beauty, and personal care products in Brazil. It operates in two segments, Pharma and Consumption. The company offers sweeteners under the Adocyl, Finn, and Zero-Cal names; and beauty and personal care products, including bleach and hydrogen peroxide, body deodorants, colognes, coloring, deodorants, hair line, hair styling, nail polish, shaving products, skin care, soap, and tanner/sunscreen products. It also provides child care and health products, such as absorbents, adult line, antiseptics, baby bottles, baby lines, baby powder, toothbrushes and dental products, cloth moistened, condoms, baby diapers, dental creams and gels, dental floss and tapes, diaper rash cream, disposable pads, disposable underwear, feminine hygiene products, diapers, intimate hygiene products, kids lines, lubricants, moistened towels, oral antiseptics, oral supplements, palinets, wet wipes, and cottons. In addition, the company offers pharmaceutical products, including over-the-counter medications, such as laxative, antacid, antispasmodic, topical antiseptic, topical, nasal decongestant drugs, and other products; prescription medications under the Farmasa, Neo Química, and Luper names; generic medications; and dermocosmetics. Hypermarcas S.A. was founded in 2001 and is headquartered in São Paulo, Brazil.

12,935 Employees
Last Reported Date: 02/6/15
Founded in 2001

hypermarcas sa (HYPE3) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hypermarcas sa (HYPE3) Key Developments

Hypermarcas S.A. Announces Unaudited Consolidated Earnings Results for the Second Quarter of 2015

Hypermarcas S.A. announced unaudited consolidated earnings results for the second quarter of 2015. For the quarter, the company reported net revenue BRL 1,256 million, representing a 10.8% growth in the quarter, accumulating a 13.1% growth in the first half of the year on the same comparable basis. Adjusted EBITDA for the quarter was BRL 297 million. This result was negatively impacted by devaluation of the real against the dollar in an amount of BRL 36 million, which represented a negative effect of 2.9% points on gross margins. Net income reached BRL 111 million in the second quarter, also impacted by the fact of the foreign exchange rate depreciation by about BRL 24 million.

Hypermarcas S.A., Q2 2015 Earnings Call, Jul 27, 2015

Hypermarcas S.A., Q2 2015 Earnings Call, Jul 27, 2015

Companies Reportedly Interested In Nappies Operations Of Hypermarcas

Companies have shown interest in baby and adult disposable nappies business of Hypermarcas S.A. (BOVESPA:HYPE3). At least six foreign companies reportedly are interested in the asset. Merrill Lynch with the assistance of Bradesco and Citibank has been hired to coordinate the deal.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HYPE3:BZ R$20.26 BRL +0.11

HYPE3 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bayer AG €134.05 EUR +0.176
GlaxoSmithKline PLC 1,396 GBp +7.00
Pfizer Ltd/India 2,176 INR +53.85
Reckitt Benckiser Group PLC 6,149 GBp +45.00
Sanofi €97.97 EUR +0.20
View Industry Companies

Industry Analysis


Industry Average

Valuation HYPE3 Industry Range
Price/Earnings 29.2x
Price/Sales 2.3x
Price/Book 1.5x
Price/Cash Flow 29.7x
TEV/Sales 1.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HYPERMARCAS SA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at